Fabhalta is the first oral monotherapy for previously treated and treatment-naïve adults with paroxysmal nocturnal hemoglobinuria (PNH),1,2 a chronic, rare and potentially life-threatening blood disorder 3,4 Now available in Canada, this new treatment option… Read More
Congratulations to Dr. P. Lynne Howell on receiving the 2025 Jeanne Manery-Fisher Memorial Award from the Canadian Society for Molecular Biosciences. The Jeanne Manery-Fisher Memorial Award from the Canadian Society… Read More
TORONTO, ON – Santis Health welcomes Clare Michaels as Vice President, Ontario Government Affairs. A seasoned advisor on complex issues, Clare will lead the development of client strategies, helping health care… Read More
BOSTON, MA – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner International Award “for pioneering research into the cellular and molecular mechanisms… Read More
Wearable technology aided by artificial intelligence can warn and prevent falls for patients recovering from stroke and spinal injuries. Simon Fraser University researchers are using cutting edge technology, in combination… Read More
